Overview
- Sterling Pharmaceutical Services LLC began the recall on August 20, 2026 and the FDA designated it Class II on September 21, 2026, a classification that signals possible temporary or reversible health effects.
- The FDA’s enforcement notice covers nine products totaling 747,844 units, including lubricant drops, a hypertonicity solution and a nighttime ointment.
- Walgreens-branded lubricant eye drops make up the largest single share of the recalled units with about 301,114 individual bottles and 199,600 two-count packs.
- The recall stems from a lack of assurance that the products are sterile, and the FDA warns that nonsterile eye products can cause eye infections or irritation because the eye is vulnerable to contamination.
- Consumers should compare product name, lot number and expiration date with the FDA listing, stop using any matched items, consult a health care provider for symptoms, and follow retailer or manufacturer guidance for returns or refunds where provided.